References
De Strooper B, Vassar R, Golde T Nat Rev Neurol 2010 6 99 107.
Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P et al. Nat Neurosci 2001 4 231 232.
Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS et al. Hum Mol Genet 2001 10 1317 1324.
Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A et al. Science 2006 314 664 666.
Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD et al. Nat Neurosci 2006 9 1520 1525.
Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C et al. Science 2004 304 700 703.
Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Müller T, Wende H et al. Neuron 2008 59 581 595.
Fields RD Trends Neursci 2008 31 361 370.
Bartzokis G Neurobiol Aging 2011 32 1341 1371.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Treiber, H., Hagemeyer, N., Ehrenreich, H. et al. BACE1 in central nervous system myelination revisited. Mol Psychiatry 17, 237–239 (2012). https://doi.org/10.1038/mp.2011.140
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2011.140
- Springer Nature Limited
This article is cited by
-
Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease
Molecular Neurodegeneration (2017)
-
BACE1 as a Therapeutic Target in Alzheimer’s Disease: Rationale and Current Status
Drugs & Aging (2013)
-
Signaling mechanisms regulating myelination in the central nervous system
Neuroscience Bulletin (2013)